January 2021
SAFETY OBSERVER N174
14 PAGES
Post-Brexit Guidance
MHRA Webinar
New FDA Guidance
GPvP in Peru
PUBLICATIONS / NUMBER 174
Stay on top of all key Pharmacovigilance Regulatory requirements
We do the search and bring you the regulatory information you need to achieve compliancein your Pharmacovigilance operations.
Back issues
Latest ReleaseSafety Observer 178Draft ICH E6(R3) Principles
New MedDRA Mappings
ABPI updates Guidance
FDA Regulatory Action
COVID-19 Vaccines & Safety
Safety Observer 177EU Clinical Trial Regulation
FDA and E2B requirements
Health Canada & ePI
COVID-19 Vaccines & Safety
Servier and Mediator
Safety Observer 176EMA and ISO IDMP Standards
COVID-19 Vaccines & Safety
COVID-19 Vaccines & Virus Variants
MHRA & RSI in Clinical Trials
New FDA E2B Requirement
Choose the number of users for this product
Number of users
- 1 user
- 2 to 5 users
- 6 to 14 users
- 15 to 49 users
- 50 and + users
Choose the number of users for this product
Number of users
- 1 user
- 2 to 5 users
- 6 to 14 users
- 15 to 49 users
- 50 and + users
